The role of properdin in murine zymosan-induced arthritis

Molecular Immunology

Volumn 47, Issue 7-8, 2010, Pages 1458-1466

  Dimitrova, Petya ^a   Ivanovska, Nina ^a   Schwaeble, Wilhelm ^b   Gyurkovska, Valeriya ^a   Stover, Cordula ^b  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

C5a; C5aR; Properdin; Proteoglycan loss; STAT1; Zymosan induced arthritis

Indexed keywords

COMPLEMENT COMPONENT C5A; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; PROPERDIN; PROTEOGLYCAN; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE EROSION; CARTILAGE DEGENERATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; SPLEEN CELL; TH1 CELL;

ANIMALS; ARTHRITIS; COMPLEMENT C5A; CYTOKINES; DISEASE PROGRESSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROPERDIN; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; SYNOVITIS; ZYMOSAN;

MURINAE; MUS;

EID: 77950626954     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.02.007     Document Type: Article

References (45)

1. Arend W.P. The innate immune system in rheumatoid arthritis. Arthritis Rheum. 2001, 44:2224-2234.
2. Ariizumi K., Shen G.L., Shikano S., Xu S., Ritter R., Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 2000, 275:20157-20167.
3. Banda N.K., Levitt B., Glogowska M.J., Thurman J.M., Takahashi K., Stahl G.L., Tomlinson S., Arend W.P., Holers V.M. Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice. J. Immunol. 2009, 183:5928-5937.
4. Banda N.K., Levitt B., Wood A.K., Takahashi K., Stahl G.L., Holers V.M., Arend W.P. Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro. Clin. Exp. Immunol. 2009, 159:100-108.
5. Banda N.K., Takahashi K., Wood A.K., Holers V.M., Arend W.P. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J. Immunol. 2007, 179:4101-4109.
6. Banda N.K., Thurman J.M., Kraus D., Wood A., Carroll M.C., Arend W.P., Holers V.M. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J. Immunol. 2006, 177:1904-1912.
7. Brouwer N., Dolman K.M., van Zwieten R., Nieuwenhuys E., Hart M., Aarden L.A., Roos D., Kuijpers T.W. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol. Immunol. 2006, 43:2051-2060.
8. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 2003, 197:1119-1124.
9. Crockard A.D., Thompson J.M., McBride S.J., Edgar J.D., McNeill T.A., Bell A.L. Markers of inflammatory activation: upregulation of complement receptors CR1 and CR3 on synovial fluid neutrophils from patients with inflammatory joint disease. Clin. Immunol. Immunopathol. 1992, 65:135-142.
10. de Ceulaer C., Papazoglou S., Whaley K. Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and synovial membrane cells from patients with rheumatoid arthritis. Immunology 1980, 41:37-43.
11. de Hooge A.S., van de Loo F.A., Koenders M.I., Bennink M.B., Arntz O.J., Kolbe T., van den Berg W.B. Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum. 2004, 50:2014-2023.
12. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 2002, 39:531-536.
13. Dimitrova P., Gyurkovska V., Shalova I., Saso L., Ivanovska N. Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490. J. Inflamm. (Lond.) 2009, 6:13.
14. DiScipio R.G. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan. Biochem. J. 1981, 199:485-496.
15. Fearon D.T., Austen K.F. Activation of the alternative complement pathway due to resistance of zymosan-bound. Proc. Natl. Acad. Sci. U.S.A. 1977, 74:1683-1687.
16. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996, 14:397-440.
17. Frasnelli M.E., Tarussio D., Chobaz-Peclat V., Busso N., So A. TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Res. Ther. 2005, 7:R370-R379.
18. Fujita T., Matsushita M., Endo Y. The lectin-complement pathway-its role in innate immunity and evolution. Immunol. Rev. 2004, 198:185-202.
19. Granucci F., Feau S., Angeli V., Trottein F., Ricciardi-Castagnoli P. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J. Immunol. 2003, 170:5075-5081.
20. Gulati P., Guc D., Lemercier C., Lappin D., Whaley K. Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium. Rheumatol. Int. 1994, 14:13-19.
21. Harboe M., Mollnes T.E. The alternative complement pathway revisited. J. Cell. Mol. Med. 2008, 12:1074-1084.
22. Hashizume M., Hayakawa N., Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford) 2008, 47:1635-1640.
23. Hietala M.A., Jonsson I.M., Tarkowski A., Kleinau S., Pekna M. Complement deficiency ameliorates collagen-induced arthritis in mice. J. Immunol. 2002, 169:454-459.
24. Hietala M.A., Nandakumar K.S., Persson L., Fahlen S., Holmdahl R., Pekna M. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur. J. Immunol. 2004, 34:1208-1216.
25. Hourcade D.E. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J. Biol. Chem. 2006, 281:2128-2132.
26. Ivanovska N.D., Dimitrova P.A., Luckett J.C., El-Rachkidy Lonnen R., Schwaeble W.J., Stover C.M. Properdin deficiency in murine models of nonseptic shock. J. Immunol. 2008, 180:6962-6969.
27. Jose P.J., Moss I.K., Maini R.N., Williams T.J. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann. Rheum. Dis. 1990, 49:747-752.
28. Keystone E.C., Schorlemmer H.U., Pope C., Allison A.C. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum. 1977, 20:1396-1401.
29. Kim S., Koga T., Isobe M., Kern B.E., Yokochi T., Chin Y.E., Karsenty G., Taniguchi T., Takayanagi H. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 2003, 17:1979-1991.
30. Kimura Y., Miwa T., Zhou L., Song W.C. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 2008, 111:732-740.
31. Kyburz D., Rethage J., Seibl R., Lauener R., Gay R.E., Carson D.A., Gay S. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum. 2003, 48:642-650.
32. Lutz H.U., Miescher S. Natural antibodies in health and disease: an overview of the first international workshop on natural antibodies in health and disease. Autoimmun. Rev. 2008, 7:405-409.
33. Morgan B.P., Daniels R.H., Williams B.D. Measurement of terminal complement complexes in rheumatoid arthritis. Clin. Exp. Immunol. 1988, 73:473-478.
34. Moxley G., Ruddy S. Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum. 1985, 28:1089-1095.
35. Okroj M., Heinegard D., Holmdahl R., Blom A.M. Rheumatoid arthritis and the complement system. Ann. Med. 2007, 39:517-530.
36. Onuma H., Masuko-Hongo K., Yuan G., Sakata M., Nakamura H., Kato T., Aoki H., Nishioka K. Expression of the anaphylatoxin receptor C5aR (CD88) by human articular chondrocytes. Rheumatol. Int. 2002, 22:52-55.
37. Pettit A.R., Ji H., von Stechow D., Muller R., Goldring S.R., Choi Y., Benoist C., Gravallese E.M. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am. J. Pathol. 2001, 159:1689-1699.
38. Schenkein H.A., Ruddy S. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for zymosan enhances alternative pathway activation by zymosan. J. Immunol. 1981, 126:7-10.
39. Schenkein H.A., Ruddy S. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway. J. Immunol. 1981, 126:11-15.
40. Stover C.M., Luckett J.C., Echtenacher B., Dupont A., Figgitt S.E., Brown J., Männel D.N., Schwaeble W.J. Properdin plays a protective role in polymicrobial septic peritonitis. J. Immunol. 2008, 180:3313-3318.
41. Swaak A.J., Van Rooyen A., Planten O., Han H., Hattink O., Hack E. An analysis of the levels of complement components in the synovial fluid in rheumatic diseases. Clin. Rheumatol. 1987, 6:350-357.
42. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M., Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999, 401:811-815.
43. Volman T.J., Hendriks T., Goris R.J. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 2005, 23:291-297.
44. Yoshitake F., Itoh S., Narita H., Ishihara K., Ebisu S. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. J. Biol. Chem. 2008, 283:11535-11540.
45. Zhang X., Kimura Y., Fang C., Zhou L., Sfyroera G., Lambris J.D., Wetsel R.A., Miwa T., Song W.C. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007, 110:228-236.